Our Clinical Trials
Select your nearest location above for the full list of local trials, or scroll though the latest studies below.
There is evidence to suggest that cannabidiol (CBD) may be beneficial in the treatment of sleep disorders. Although this is positive, more research is required to investigate the therapeutic effect of CBD in reducing sleep disturbances.
There is evidence to suggest that cannabidiol (CBD) may be beneficial in the treatment of sleep disorders. Although this is positive, more research is required to investigate the therapeutic effect of CBD in reducing sleep disturbances.
There is evidence to suggest that cannabidiol (CBD) may be beneficial in the treatment of sleep disorders. Although this is positive, more research is required to investigate the therapeutic effect of CBD in reducing sleep disturbances.
There is evidence to suggest that cannabidiol (CBD) may be beneficial in the treatment of sleep disorders. Although this is positive, more research is required to investigate the therapeutic effect of CBD in reducing sleep disturbances.
Learn more about participating in a clinical trial for a potential vaccine to prevent respiratory syncytial virus infection. By participating in this trial, you might change the future of RSV.
This Phase 3, randomised, placebo-controlled, observer-blind clinical trial is designed to evaluate the safety, efficacy and immunogenicity of an investigational vaccine (mRNA-1647) for CMV in healthy volunteers.
A Phase 3 Clinical Study to Evaluate the Safety and Immunogenicity of Experimental Pneumococcal Vaccine.
This Phase 3, randomised, placebo-controlled, observer-blind clinical trial is designed to evaluate the safety, efficacy and immunogenicity of an investigational vaccine (mRNA-1647) for CMV in healthy volunteers.
This Phase 3, randomised, placebo-controlled, observer-blind clinical trial is designed to evaluate the safety, efficacy and immunogenicity of an investigational vaccine (mRNA-1647) for CMV in healthy volunteers.
Learn more about participating in a clinical trial for a potential vaccine to prevent respiratory syncytial virus infection. By participating in this trial, you might change the future of RSV.
Paratus Clinical is modern, independent and purpose-built to conduct clinical trials in Australia, with a focus on better recruitment and high quality standards that deliver cost-effective trials.
T: 1300 742 326
